Klaus Markstaller Selected Research

Pulmonary Atelectasis

1/2018	Intermittent Hypoxia Activates Duration-Dependent Protective and Injurious Mechanisms in Mouse Lung Endothelial Cells.
3/2015	Influence of inspiration to expiration ratio on cyclic recruitment and derecruitment of atelectasis in a saline lavage model of acute respiratory distress syndrome.
11/2014	Hints for cyclical recruitment of atelectasis during ongoing mechanical ventilation in lavage and oleic acid lung injury detected by SpO₂ oscillations and electrical impedance tomography.
3/2013	Influence of fluid and volume state on PaO2 oscillations in mechanically ventilated pigs.
6/2010	Observation of ventilation-induced Spo(2) oscillations in pigs: first step to noninvasive detection of cyclic recruitment of atelectasis?
12/2009	A comparison of micropore membrane inlet mass spectrometry-derived pulmonary shunt measurement with Riley shunt in a porcine model.
10/2008	Effect of chest compressions only during experimental basic life support on alveolar collapse and recruitment.
1/2007	Maintenance of end-expiratory recruitment with increased respiratory rate after saline-lavage lung injury.
6/2006	The implications of arterial Po2 oscillations for conventional arterial blood gas analysis.
11/2005	Analysis of atelectasis, ventilated, and hyperinflated lung during mechanical ventilation by dynamic CT.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Klaus Markstaller Research Topics

Disease

12	Pulmonary Atelectasis 01/2018 - 06/2002
7	Hypoxia (Hypoxemia) 02/2021 - 02/2016
7	Lung Injury 11/2014 - 12/2002
5	COVID-19 03/2022 - 01/2020
5	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 03/2022 - 06/2008
5	Hyperoxia 12/2021 - 01/2017
4	Acute Lung Injury 01/2014 - 05/2008
3	Pulmonary Edema 09/2021 - 09/2013
3	Edema (Dropsy) 09/2021 - 05/2008
3	Inflammation (Inflammations) 02/2021 - 01/2018
3	Necrosis 01/2017 - 09/2013
2	Reperfusion Injury 02/2021 - 01/2018
2	Respiratory Insufficiency (Respiratory Failure) 10/2019 - 09/2013
2	Critical Illness (Critically Ill) 07/2017 - 10/2013
2	Heart Arrest (Cardiac Arrest) 10/2008 - 04/2005
1	Burns 02/2021
1	Shock 01/2020
1	Fever (Fevers) 01/2020
1	Ventilator-Induced Lung Injury 03/2019
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2018
1	Pulmonary Hypertension 01/2018
1	Vascular Diseases (Vascular Disease) 01/2018
1	Obstructive Sleep Apnea 01/2018
1	Primary Graft Dysfunction 09/2017
1	Body Weight (Weight, Body) 01/2014
1	Hypovolemia 03/2013
1	Apnea 10/2011
1	Ventricular Fibrillation 10/2008
1	Bronchiolitis Obliterans Syndrome 03/2008
1	Bronchiolitis Obliterans 03/2008

Drug/Important Bio-Agent (IBA)

9	Oxygen (Dioxygen)IBA 01/2021 - 03/2008
3	ArgonIBA 01/2018 - 01/2016
3	Interleukin-8 (Interleukin 8)IBA 01/2017 - 05/2008
3	Surface-Active Agents (Surfactants)IBA 03/2015 - 06/2006
2	LectinsIBA 12/2021 - 09/2013
2	CytokinesIBA 01/2021 - 02/2016
2	EnzymesIBA 01/2021 - 05/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 02/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2017 - 01/2017
2	salicylhydroxamic acid (SHAM)IBA 11/2014 - 12/2009
2	Oleic Acid (Oleate)IBA 11/2014 - 09/2013
2	pepBs1-Ac peptideIBA 01/2014 - 09/2013
1	Polysaccharides (Glycans)IBA 12/2021
1	Small Interfering RNA (siRNA)IBA 12/2021
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 12/2021
1	AP301 peptideIBA 09/2021
1	Peptides (Polypeptides)IBA 09/2021
1	Carbon MonoxideIBA 02/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	E-SelectinIBA 01/2021
1	Peroxynitrous Acid (Peroxynitrite)IBA 01/2021
1	AntioxidantsIBA 01/2021
1	Ropivacaine (Naropin)FDA LinkGeneric 01/2020
1	Local AnestheticsIBA 01/2020
1	Prostaglandins DIBA 09/2017
1	Epithelial Sodium ChannelsIBA 09/2017
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2017
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2017
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 02/2016
1	Macrophage Migration-Inhibitory FactorsIBA 02/2016
1	Crystalloid SolutionsIBA 01/2014
1	6-fluoro-6-desoxyoxymorphone (FOXY)IBA 10/2011
1	Indicators and Reagents (Reagents)IBA 06/2010
1	Ringer's LactateIBA 12/2009
1	GasesIBA 10/2008
1	ChemokinesIBA 05/2008

Therapy/Procedure

8	Artificial Respiration (Mechanical Ventilation) 01/2022 - 11/2005
5	Therapeutics 01/2020 - 06/2008
4	Mechanical Ventilators (Ventilator) 01/2012 - 12/2002
3	Lung Transplantation 03/2022 - 03/2008
3	Extracorporeal Membrane Oxygenation 01/2022 - 01/2020
3	Critical Care (Surgical Intensive Care) 11/2020 - 06/2010
3	Bioreactors (Bioreactor) 01/2017 - 02/2016
3	Cardiopulmonary Resuscitation (CPR) 10/2008 - 06/2002
1	Hyperbaric Oxygenation 02/2021
1	Epidural Analgesia 01/2020
1	Continuous Renal Replacement Therapy 07/2017
1	Transplantation 01/2017
1	Anesthesia 01/2014